Fundraising FoxArrepath
3 known investors
Find your way into Arrepath
Sign up to find every way you can get introduced to Arrepath
- Your email: who you already know at Arrepath, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arrepath team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ArrePath is a biotechnology company that applies AI/ML to drug discovery and development. The company leverages computational platforms and data science to accelerate the identification and advancement of new therapeutic candidates across multiple disease areas.
Founders & leadership
ZG
Zemer GitaiFounder and SAB Chair
KK
Kevin KrausePresident and Chief Executive Officer
Investors · 3
Innospark Ventures✓ confirmed by ArrepathBoston · $2M
How we know: the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Insight Partners✓ confirmed by ArrepathNew York · $120M – $350M
How we know: the company's own site · Insight Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Arrepath do?
- ArrePath is a biotechnology company that applies AI/ML to drug discovery and development. The company leverages computational platforms and data science to accelerate the identification and advancement of new therapeutic candidates across multiple disease areas.
- Who founded Arrepath?
- Arrepath was founded by Zemer Gitai.
- Who are Arrepath's investors?
- Arrepath's investors include Innospark Ventures, Insight Partners, Boehringer Ingelheim Venture Fund.